Skip to main content
Frontiers in Aging logoLink to Frontiers in Aging
. 2022 Apr 13;3:865178. doi: 10.3389/fragi.2022.865178

Association of Vitamin K Insufficiency as Evaluated by Serum Undercarboxylated Osteocalcin With Frailty in Community-Dwelling Older Adults

Kotaro Azuma 1, Yosuke Osuka 2, Narumi Kojima 2, Hiroyuki Sasai 2, Hunkyung Kim 2, Satoshi Inoue 1,*
PMCID: PMC9261387  PMID: 35821817

Abstract

Frailty is the state of having a reduced ability to recover from stress. Intervention in frailty is important for fulfilling healthy longevity. Vitamin K is a fat-soluble vitamin contained in vegetables and fermented foods. Although vitamin K is shown to be associated with several age-related diseases, studies on the association of vitamin K intake and frailty in the elderly population are limited. In the present study, a total of 800 community-dwelling older adults (mean age = 75.9) were recruited for a comprehensive geriatric health examination, including frailty evaluation based on the Japanese version of the Cardiovascular Health Study criteria. Serum concentrations of total osteocalcin (OC) and undercarboxylated osteocalcin (ucOC) were measured. The ratio of ucOC and OC (ucOC/OC), which reflects vitamin K insufficiency, was calculated for each participant, and the values were divided into quartiles. A binary logistic regression analysis was performed to evaluate the risk of frailty for each quartile of ucOC/OC, with the lowest quartile as the reference. Significant association of frailty and the highest quartile of ucOC/OC was found with the odds ratio of 2.49 (p = 0.023) with adjustment with age, sex, body mass index, dietary intake, and several clinical characteristics. When the analysis was repeated in each component of frailty, the highest quartiles of ucOC/OC had the tendency of association with “slow walking speed” and “low activity.” Our findings demonstrated the association between vitamin K insufficiency and frailty in the elderly population. Our analysis also suggests that vitamin K insufficiency could be associated with selected components of frailty.

Keywords: vitamin K, undercarboxylated osteocalcin (ucOC), osteocalcin (OC), frailty, cross-sectional study

Introduction

Vitamin K is a fat-soluble vitamin contained in vegetables and fermented foods (Suttie and Booth, 2011; Fu et al., 2017; Tarvainen et al., 2019). Vitamin K contained in foods is classified into two forms, namely, vitamin K1 (phylloquinone) and K2 (menaquinone). Vitamin K1 is abundant in vegetables (Suttie and Booth, 2011), whereas vitamin K2 is synthesized by microorganisms and is contained in fermented foods such as fermented soybeans (called “natto” in Japanese) (Fu et al., 2017; Tarvainen et al., 2019). Vitamin K was originally discovered as an essential factor for blood coagulation (Dam, 1935). Classically, the functions of vitamin K are explained by its role as an essential co-factor for the post-transcriptional modification of the proteins which is catalyzed by γ-glutamyl carboxylase (GGCX) (Nelsestuen et al., 1974; Stenflo et al., 1974). Substrates of GGCX include several coagulation factors (Nelsestuen et al., 1974; Stenflo et al., 1974; Bucher et al., 1976), matrix Gla protein (MGP) (Price et al., 1983), and osteocalcin (OC) (Price et al., 1976). To date, vitamin K is shown to function by other mechanisms, including transcriptional activation as a ligand for steroid and xenobiotic receptors (SXR) (Tabb et al., 2003; Azuma and Inoue, 2019). The latter function of vitamin K as an SXR ligand has been shown only in vitamin K2. Meanwhile, vitamin K1 can function as vitamin K2 since vitamin K1 is known to be converted to vitamin K2 by UbiA prenyltransferase domain–containing protein l (UBIAD1) in the mammalian body (Nakagawa et al., 2010).

Other than its clinical role in blood coagulation, vitamin K status is also associated with age-related diseases including osteoporosis (Booth et al., 2000; Kaneki et al., 2001; Yaegashi et al., 2008) and osteoarthritis (Neogi et al., 2006; Oka et al., 2009; Misra et al., 2013). By some clinical observational studies, vitamin K status was reported to be correlated with physical performance such as gait speed, hand grip strength, and mobility (Shea et al., 2016; van Ballegooijen et al., 2018; Shea et al., 2020; Smith et al., 2021), suggesting that vitamin K status may also be involved in sarcopenia. Sarcopenia is one of the underlying conditions of frailty, which is a state of reduced ability to recover from stress and is considered a reversible pre-disability stage. In older adults, conditions or diseases including falls and fractures, postoperative complications, disability, institutionalization, and mortality are shown to be outcomes of frailty (Fried et al., 2001).

Several epidemiological studies showed that frailty could be associated with the dietary pattern. Mediterranean diet was associated with the decreased risk of frailty (Kojima et al., 2018). Intake of fat-soluble vitamins such as vitamin A, D, and E was negatively associated with frailty prevalence (Hernández Morante et al., 2019; Pilleron et al., 2019). An observational study conducted in the Netherlands reported that vitamin K insufficiency evaluated by plasma dephospho-uncarboxylated matrix Gla protein (dp-ucMGP) was associated with a higher prevalence of frailty (Machado-Fragua et al., 2020). In the report, the dp-ucMGP of the population between 55 and 65 years old was analyzed (Machado-Fragua et al., 2020). As far as we know, the association of vitamin K status with frailty in the older adult population, nor the vitamin K status evaluated by undercarboxylated osteocalcin (ucOC) with frailty, has not been reported so far. We conducted a cross-sectional study in which the association of vitamin K status and frailty in a community-dwelling Japanese older adult population was examined. We utilized the ratio of the serum concentration of ucOC and total OC (ucOC/OC) as an indicator of vitamin K insufficiency. A higher value of ucOC/OC indicates a vitamin K insufficient state, which was validated with the actual vitamin K concentration in a previous study (Tsugawa et al., 2006).

Materials and Methods

Study Design

In 2020, a total of 800 people (mean age = 75.9) were recruited as a follow-up study of the baseline examinations conducted from 2017 to 2019 by mailing community-dwelling older adults randomly from the Basic Resident Register of the Itabashi district in metropolitan Tokyo. Among them, 88.8% (710 people) were females. They were invited to a comprehensive geriatric health examination, including a frailty evaluation and blood test. Information on past medical history and dietary intake is obtained by using a self-reporting questionnaire. Grip strength and walking speed were measured by the staff of the Tokyo Metropolitan Institute of Gerontology. For the measurement of walking speed, participants were asked to walk for 11 m, and the walking time required for the 5 m in the middle of the way was then measured. Frailty was evaluated by the Japanese version of the Cardiovascular Health Study criteria (Satake et al., 2017). The five components of frailty, namely, “shrinking,” “weakness,” “exhaustion,” “slowness,” and “low activity,” were evaluated. People having more than two components were judged as being frail. “Shrinking” was defined as unintentional body weight loss equal to or more than 3 kg in the past 6 months. “Weakness” was defined as having a hand-grip strength of less than 26 kg (male) or 18 kg (female). “Exhaustion” was judged as positive when the participants answered “Yes” to the question, “Do you feel tired without a reason for the past 2 weeks?” “Slowness” was defined as a walking speed of less than 1.0 m/s. “Low activity” was judged positive when the participants answered “No” to both the questions, “Do you engage in moderate levels of physical exercise or sports aimed at health?” and “Do you engage in low levels of physical exercise aimed at health?” Serum OC and ucOC concentration were measured by BML Inc. (Tokyo, Japan). This study was approved by the institutional ethical committee of the Tokyo Metropolitan Institute of Gerontology (approval number: H18-17, R1-20). All participants provided written informed consent.

Statistical Analyses

The serum ucOC/OC values are divided into quartiles (Q1, Q2, Q3, and Q4). Descriptive statistics were used to compare patients’ characteristics according to the levels of ucOC/OC using one-way analysis of variance for continuous variables and a chi-square test for categorical variables. Binary logistic regression analysis was performed to evaluate the association of frailty with the following variables: age (continuous), sex (binary), body mass index (categorical; <18.5, 18.5–25, 25–30, and 30+), hypertension (binary), stroke (binary), heart disease (binary), diabetes (binary), dyslipidemia (binary), osteoporosis (binary), smoking status (binary, both current smokers and ex-smokers are defined as having positive smoking status), ucOC/OC (categorical), and dietary intake (categorical). Components of dietary intake used for the analysis include meat, fish, eggs, soybean products, milk, cheese, potatoes, vegetables, fruits, seaweeds, and “oils and fats.” Vegetables are specified to be dark-colored vegetables, including carrots, spinach, pumpkins, and tomatoes. “Oils and fats” indicate stir-fried foods, butter, and margarine. Dietary intake was positive when the frequency of intake was nearly every day. In the chi-square test, the specific intake of “fermented soybeans,” one of the soybean products, was included in the analysis. In the case of fermented soybeans, the frequency of intake of more than 3 days a week was defined as positive. Binary logistic regression analysis was repeated to evaluate the association of each component of frailty (shrinking, weakness, exhaustion, slowness, and low activity) with the same variables in the analysis of frailty itself. IBM SPSS Statistics version 25 software (IBM Corporation, Armonk, NY, United States) was used for all statistical analyses.

Results

The characteristics of the study population according to the levels of serum ucOC/OC divided into quartiles are summarized in Table 1. Among the participants, 55 (6.9%) were frail according to the criteria. The frequent intake of fermented soybeans showed a significantly negative correlation with a high value of ucOC/OC (p < 0.001 in chi square test). Since the fermented soybeans contain a high amount of vitamin K2 (Tarvainen et al., 2019), this result can be regarded as one of the validations that ucOC/OC is serving as an indicator of vitamin K insufficiency in our study. Meanwhile, ucOC/OC was not associated with the intake of soybean products as a whole, which contains other soybean products including “miso” and “tofu” together with fermented soybeans. The association of ucOC/OC and the intake of vegetables, which are a known source of vitamin K1, were not detected, either.

TABLE 1.

Characteristics of the study populations according to the levels of ucOC/OC a .

Characteristic ucOC/OC p value b Total
Q1 Q2 Q3 Q4
ucOC/OC <0.1627 0.1627–0.1942 0.1942–0.2324 >0.2324
N 200 200 200 200 800
Age (year) 76.5 ± 4.8 75.9 ± 4.7 75.8 ± 4.7 75.5 ± 5.3 0.193 75.9 ± 4.9
Female 170 (85.0%) 173 (86.5%) 185 (92.5%) 182 (91.0%) 0.054 710 (88.8%)
BMI 22.8 ± 3.2 23.1 ± 3.3 32.4 ± 3.1 23.3 ± 3.6 0.297 23.2 ± 3.3
Hypertension 90 (45.0%) 69 (34.5%) 91 (45.5%) 91 (45.5%) 0.065 341 (42.6%)
Stroking status 2 (1.0%) 1 (0.5%) 7 (3.5%) 10 (5.0%) 0.012 20 (2.5%)
Heart disease 35 (17.5%) 25 (12.5%) 23 (11.5%) 28 (14.1%) 0.326 111 (13.9%)
Diabetes 37 (18.6%) 21 (10.5%) 27 (13.5%) 18 (9.0%) 0.023 103 (12.9%)
Dyslipidemia 100 (50.5%) 94 (47.0%) 92 (46.2%) 94 (47.0%) 0.831 380 (47.5%)
Osteoporosis 79 (40.1%) 55 (27.6%) 44 (22.1%) 41 (20.6%) < 0.001 219 (27.4%)
Smoking status c 59 (29.5%) 41 (20.5%) 42 (21.0%) 49 (24.5%) 0.128 191 (23.9%)
Frailty 15 (7.5%) 10 (5.0%) 8 (4.0%) 22 (11.0%) 0.028 55 (6.9%)
Dietary intake d
 Meat 77 (38.5%) 74 (37.0%) 57 (28.5%) 68 (34.0%) 0.159 276 (34.5%)
 Fish 67 (33.5%) 65 (32.5%) 71 (35.5%) 70 (35.0%) 0.918 273 (34.1%)
 Eggs 91 (45.5%) 84 (42.0%) 66 (33.0%) 85 (42.5%) 0.065 326 (40.8%)
 Soybean products 103 (51.5%) 101 (50.5%) 104 (52.0%) 98 (49.0%) 0.936 406 (50.8%)
 Fermented soybeans e 112 (56.0%) 107 (53.5%) 91 (45.5%) 63 (31.5%) < 0.001 373 (46.6%)
 Milk 109 (54.5%) 119 (59.5%) 104 (52.0%) 104 (52.0%) 0.388 436 (54.5%)
 Cheese 36 (18.0%) 47 (23.6%) 29 (14.5%) 38 (19.0%) 0.138 150 (18.8%)
 Potatoes 21 (10.5%) 13 (6.5%) 15 (7.5%) 24 (12.0%) 0.191 73 (9.1%)
 Vegetables 138 (69.0%) 129 (64.5%) 124 (62.0%) 127 (63.5%) 0.496 518 (64.8%)
 Fruits 119 (59.5%) 114 (57.0%) 113 (56.5%) 113 (56.5%) 0.918 459 (57.4%)
 Seaweeds 37 (18.5%) 43 (21.5%) 38 (19%) 43 (21.5%) 0.812 161 (20.1%)
 Oils and fats 114 (57.0%) 116 (58.3%) 92 (46.2%) 106 (53.0%) 0.070 428 (53.6%)
a

Values are means ± SDs, for continuous variables or frequency (%) for categorical variables.

b

p values are for one-way analysis of variance (continuous variables) and the chi-square test (categorical variables).

c

Current smokers and ex-smokers are included.

d

Numbers and ratios of the participants who consume the indicated food or drink nearly every day are shown, except for the intake of fermented soybeans.

e

Numbers and ratios of the participants who consume fermented soybeans more than 3 days a week are shown.

Significant p values (p < 0.05) are expressed in bold italics, and p values less than 0.1 (0.05 ≤ p < 0.1) are expressed in italics.

Abbreviations: BMI, body mass index; OC, osteocalcin; ucOC, undercarboxylated osteocalcin.

Next, binary logistic regression analysis was performed to determine the association between frailty and each characteristic, including age, sex, body mass index, hypertension, stroke, heart disease, diabetes, dyslipidemia, osteoporosis, smoking status, dietary intake, and ucOC/OC. Among them, age, hypertension, diabetes, osteoporosis, and the highest quartile (Q4) of ucOC/OC with the lowest quartile (Q1) as the reference were significantly associated with frailty (Table 2). The odds ratio (OR) of the highest quartile (Q4) of ucOC was 2.49, and its 95% confidence interval (CI) was from 1.13 to 5.45 (p = 0.023). These results indicated that older age, hypertension, diabetes, osteoporosis, and vitamin K insufficiency are associated with frailty. In addition, the body mass index between 25 and 30 and the positive smoking status tended to correlate with frailty (Table 2).

TABLE 2.

Association of characteristics with frailty.

Characteristic B OR (95% CI) p value
Age 0.108 1.12 (1.04–1.19) 0.001
Sex (women) 0.362 1.44 (0.50–4.11) 0.499
BMI
 <18.5 0.497 1.64 (0.50–5.42) 0.415
 18.5–25 Ref
 25–30 0.580 1.79 (0.93–3.44) 0.082
 30 < 0.695 2.00 (0.40–9.93) 0.395
Hypertension 0.637 1.89 (1.00–3.56) 0.049
Stroke 0.297 1.35 (0.34–5.37) 0.674
Heart disease 0.171 1.19 (0.56–2.52) 0.656
Diabetes 0.818 2.27 (1.08–4.74) 0.030
Dyslipidemia 0.081 1.08 (0.57–2.05) 0.804
Osteoporosis 0.912 2.49 (1.27–4.89) 0.008
Smoking status 0.678 1.97 (0.93–4.17) 0.077
ucOC/OC
 Q1 Ref
 Q2 0.129 1.14 (0.46–2.81) 0.780
 Q3 −0.304 0.74 (0.28–1.94) 0.538
 Q4 0.910 2.49 (1.13–5.45) 0.023
Dietary intake a
 Meat −0.363 0.70 (0.33–1.45) 0.332
 Fish −0.062 0.94 (0.45–1.95) 0.868
 Eggs 0.341 1.41 (0.75–2.65) 0.293
 Soybean products 0.051 1.05 (0.54–2.05) 0.882
 Milk 0.182 1.20 (0.64–2.26) 0.573
 Cheese −0.477 0.62 (0.26–1.47) 0.279
 Potatoes −0.004 1.00 (0.37–2.70) 0.993
 Vegetables 0.584 1.79 (0.88–3.68) 0.111
 Fruits −0.182 0.83 (0.44–1.57) 0.573
 Seaweeds 0.082 1.09 (0.50–2.38) 0.839
 Oils and fats 0.077 1.08 (0.57–2.05) 0.814
a

Intake of indicated food or drink every day is considered positive.

Binary logistic regression analysis was performed to evaluate the association of frailty with the following variables: age (continuous), sex (binary), BMI (categorical), hypertension (binary), stroke (binary), heart disease (binary), diabetes (binary), dyslipidemia (binary), osteoporosis (binary), smoking status (binary), ucOC/OC (categorical), and dietary intake (categorical).

Abbreviations: B, logistic regression coefficient; BMI, body mass index; CI, confidence interval; OC, osteocalcin; OR, odds ratio; Ref, reference; ucOC, undercarboxylated osteocalcin.

Significant p values (p < 0.05) are expressed in bold italics, and p values less than 0.1 (0.05 ≤ p < 0.1) are expressed in italics.

Frailty is composed of five components, including shrinking (weigh loss of 2 or more kg in the past 6 months), weakness (grip strength of less than 26 kg in men or less than 18 kg in women), exhaustion (feeling of tiredness without a reason in the past 2 weeks), slowness (walking speed of less than 1.0 m/s), and low activity (no engagement in physical exercise aimed at health). When the analysis was repeated with each component of frailty, the highest quartile of ucOC/OC had a tendency of association with “slowness” (OR 1.80, 95% CI 0.91 to 3.56, and p value 0.092) and “low activity” (OR 1.64, 95% CI 0.95 to 2.83, and p value 0.075) with adjustment for age, sex, body mass index, hypertension, stroke, heart disease, diabetes, dyslipidemia, osteoporosis, smoking status, and dietary intake (Table 3). The results of our study are summarized in Figure 1.

TABLE 3.

Associations between ucOC/OC and components of frailty.

ucOC/OC
Q1 Q2 Q3 Q4
N 200 200 200 200
Components of frailty
Shrinking
  OR (95% CI) Ref 0.81 (0.43–1.51) 1.00 (0.55–1.82) 1.24 (0.70–2.22)
  p value 0.502 0.991 0.465
Weakness
  OR (95% CI) Ref 1.27 (0.76–2.11) 1.02 (0.61–1.72) 1.38 (0.83–2.30)
  p value 0.361 0.932 0.220
Exhaustion
  OR (95% CI) Ref 1.02 (0.63–1.67) 0.73 (0.44–1.22) 1.12 (0.69–1.82)
  p value 0.924 0.235 0.645
Slowness
  OR (95% CI) Ref 0.73 (0.33–1.62) 0.90 (0.42–1.90) 1.80 (0.91–3.56)
  p value 0.440 0.775 0.092
Low activity
  OR (95% CI) Ref 0.82 (0.45–1.49) 1.45 (0.83–2.53) 1.64 (0.95–2.83)
  p value 0.507 0.193 0.075

A binary logistic regression analysis was performed to evaluate the association of components of frailty with ucOC/OC (categorical). The data were adjusted for the following variables: age (continuous), sex (binary), hypertension (binary), stroke (binary), heart disease (binary), diabetes (binary), dyslipidemia (binary), osteoporosis (binary), and smoking status (binary).

p values less than 0.1 (0.05 ≤ p < 0.1) are expressed in italics.

Abbreviations: CI, confidence interval; OC, osteocalcin; OR, odds ratio; Ref, reference; ucOC, undercarboxylated osteocalcin.

FIGURE 1.

FIGURE 1

Association of vitamin K insufficiency and frailty. A diagram representing the results of the present study is shown. Vitamin K insufficiency was evaluated by the ratio of undercarboxylated osteocalcin and osteocalcin (ucOC/OC) The highest quartile of ucOC/OC, which reflects relatively weak vitamin K function in vivo, was significantly associated with frailty as determined by the Japanese version of the Cardiovascular Health Study criteria (p = 0.029), as shown in Table 2. Among the components of frailty in the criteria, the highest quartile of ucOC/OC tended to be associated with “slowness” (p = 0.092) and “low activity” (p = 0.075), as shown in Table 3.

Discussion

In the present study, we demonstrated the association of vitamin K insufficiency as evaluated by the serum ucOC/OC ratio with frailty in a community-dwelling older adult population. Furthermore, our analysis suggests that vitamin K insufficiency tended to be associated with slow walking speed and low activity.

In the epidemiological studies evaluating vitamin K insufficiency, vitamin K status has been estimated by food-frequency questionnaires (Booth et al., 2000; Oka et al., 2009), plasma concentration of dp-ucMGP (Shea et al., 2016; van Ballegooijen et al., 2018; Shea et al., 2020), ucOC/OC (Smith et al., 2021), or direct measurement of vitamin K concentration by high-performance liquid chromatography (HPLC) (Kaneki et al., 2001; Neogi et al., 2006; Misra et al., 2013; Shea et al., 2016; Shea et al., 2020). Those methods require relatively special methods and/or facilities, except for ucOC/OC, which may limit the translation of these findings into clinical settings. Since the measurements of serum ucOC and OC are simple and widely available, our study would inspire studies on diseases in which vitamin K insufficiency could be involved.

A possible association with vitamin K insufficiency and slow walking speed was in line with previous reports (Shea et al., 2016; van Ballegooijen et al., 2018). The reports on the mechanism of vitamin K action on physical performance are limited. A study using rat models showed that vitamin K increased slow-twitch muscle fibers and improved their mitochondrial function (Su et al., 2022), which may partially explain the effect of vitamin K on the muscular tissue. The effect of vitamin K on sphingolipid metabolism might be one of the underlying mechanisms. It was shown that ceramide accumulation was significantly correlated with decreased lean mass in the study of a small number of human subjects (Rivas et al., 2012), while sphingosine 1-phosphate had trophic action on denervated muscle in a rat model (Zanin et al., 2008). Since vitamin K is known to regulate sphingolipid metabolism (Lev and Milford, 1972) and warfarin treatment was shown to reduce certain types of sphingolipids in the mouse brain, including sulfatides, sphingomyelin, and cerebrosides (Sundaram and Lev, 1988), vitamin K may affect muscular performance, although the effect of vitamin K on ceramide or sphingosine 1-phosphate has not been studied yet to the best of our knowledge.

We proposed another possible association between vitamin K and “low activity.” The low activity can be caused by a sedentary lifestyle and decreased physical performance. It can be hypothesized that vitamin K may affect lifestyle by regulating psychological aspects. In an old study using vitamin K-deficient rats by administrating warfarin, hypoactivity and lack of exploratory behavior were observed (Cocchetto et al., 1985). A study using rat models demonstrated that vitamin K decreased depression-like behavior in the forced swim test and increased the score of the social interaction test (Gancheva and Zhelyazkova-Savova, 2016), which supported the possible effect of vitamin K on behavior. It is intriguing that osteocalcin was shown to be a hormone affecting behavior (Berger et al., 2019). In mice exposed to acute stress with trimethylthiazoline (fox odor), osteocalcin was released from osteoblasts and mediated the acute stress response by suppressing parasympathetic tone. In this function, ucOC is considered to be an active form, while carboxylated osteocalcin is considered to be an inactive form. In this sense, vitamin K insufficiency may be more likely to induce a fight or flight response and may transiently enhance physical performance. Meanwhile, it can be speculated that augmented stress response by vitamin K insufficiency leads to “low activity” in ordinary conditions.

We noticed that there are several limitations to this study. First, the majority of the population was females in our analysis. This problem could be overcome to some extent by using the statistical method of adjusting sex. Second, we did not have detailed information on the medications that potentially affected the function of vitamin K, such as anticoagulants. Therefore, our results may also include the effect of suppressive vitamin K function by anticoagulants on frailty. Third, we did not have information on the medication’s effect on bone turnover, which may affect the concentration of OC. Our analysis could be less susceptible to the absolute amount of OC by calculating the ratio of ucOC to OC. Since our study is an observational study, we could not discuss the cause-effect relationship between vitamin K and frailty. Considering the importance of intervention to frailty for fulfilling healthy longevity, we hope that our study could be one of the backgrounds to prompt clinical intervention studies clarifying the effect of vitamin K supplementation on the reversing frail state.

In summary, the present study demonstrated the association between vitamin K insufficiency and frailty in the older adult population. Our findings could be a clue to designing further studies on how vitamin K functions in frailty and its underlying conditions.

Acknowledgments

We thank all the participants for our study.

Data Availability Statement

The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by the ethical committee of the Tokyo Metropolitan Institute of Gerontology (approval numbers: H18-17 and R1-20). The patients/participants provided their written informed consent to participate in this study.

Author Contributions

All the authors conceived and designed the study. KA, YO, NK and HS acquired the data and KA conducted the data analyses. All authors contributed to the interpretation of data, drafted the manuscript, and approved the final version for publication.

Funding

This study was funded by TMIG institutional project funding (SASM). The funder has no role in the study design, analyses, interpretation of the results, decision to publish, or in the preparation or approval of the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  1. Azuma K., Inoue S. (2019). Multiple Modes of Vitamin K Actions in Aging-Related Musculoskeletal Disorders. Ijms 20, 2844. 10.3390/ijms20112844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berger J. M., Singh P., Khrimian L. (2019). Mediation of the Acute Stress Response by the Skeleton. Cell Metab 30, 890–902. e8. 10.1016/j.cmet.2019.08.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Booth S. L., Tucker K. L., Chen H., Hannan M. T., Gagnon D. R., Cupples L. A., et al. (2000). Dietary Vitamin K Intakes Are Associated with Hip Fracture but Not with Bone mineral Density in Elderly Men and Women. Am. J. Clin. Nutr. 71, 1201–1208. 10.1093/ajcn/71.5.1201 [DOI] [PubMed] [Google Scholar]
  4. Bucher D., Nebelin E., Thomsen J., Stenflo J. (1976). Identification of γ-carboxyglutamic Acid Residues in Bovine Factors IX and X, and in a New Vitamin K-dependent Protein. FEBS Lett. 68, 293–296. 10.1016/0014-5793(76)80456-5 [DOI] [PubMed] [Google Scholar]
  5. Cocchetto D. M., Miller D. B., Miller L. L., Bjornsson T. D. (1985). Behavioral Perturbations in the Vitamin K-Deficient Rat. Physiol. Behav. 34, 727–734. 10.1016/0031-9384(85)90371-3 [DOI] [PubMed] [Google Scholar]
  6. Dam H. (1935). The Antihaemorrhagic Vitamin of the Chick. Biochem. J. 29, 1273–1285. 10.1042/bj0291273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fried L. P., Tangen C. M., Walston J., Newman A. B., Hirsch C., Gottdiener J., et al. (2001). Frailty in Older Adults: Evidence for a Phenotype. Journals Gerontol. Ser. A: Biol. Sci. Med. Sci. 56, M146–M157. 10.1093/gerona/56.3.m146 [DOI] [PubMed] [Google Scholar]
  8. Fu X., Harshman S. G., Shen X., Haytowitz D. B., Karl J. P., Wolfe B. E., et al. (2017). Multiple Vitamin K Forms Exist in Dairy Foods. Curr. Dev. Nutr. 1, e000638. 10.3945/cdn.117.000638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gancheva S. M., Zhelyazkova-Savova M. D. (2016). Vitamin K2 Improves Anxiety and Depression but Not Cognition in Rats with Metabolic Syndrome: a Role of Blood Glucose? Folia Med. (Plovdiv) 58, 264–272. 10.1515/folmed-2016-0032 [DOI] [PubMed] [Google Scholar]
  10. Hernández Morante J. J., Gómez Martínez C., Morillas-Ruiz J. M. (2019). Dietary Factors Associated with Frailty in Old Adults: A Review of Nutritional Interventions to Prevent Frailty Development. Nutrients 11, 102. 10.3390/nu11010102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kaneki M., Hedges S. J., Hosoi T., Fujiwara S., Lyons A., Crean S. J., et al. (2001). Japanese Fermented Soybean Food as the Major Determinant of the Large Geographic Difference in Circulating Levels of Vitamin K2. Nutrition 17, 315–321. 10.1016/s0899-9007(00)00554-2 [DOI] [PubMed] [Google Scholar]
  12. Kojima G., Avgerinou C., Iliffe S., Walters K. (2018). Adherence to Mediterranean Diet Reduces Incident Frailty Risk: Systematic Review and Meta-Analysis. J. Am. Geriatr. Soc. 66, 783–788. 10.1111/jgs.15251 [DOI] [PubMed] [Google Scholar]
  13. Lev M., Milford A. F. (1972). Effect of Vitamin K Depletion and Restoration on Sphingolipid Metabolism in Bacteroides Melaninogenicus. J. Lipid Res. 13, 364–370. 10.1016/s0022-2275(20)39399-8 [DOI] [PubMed] [Google Scholar]
  14. Machado-Fragua M. D., Hoogendijk E. O., Struijk E. A., et al. (2020). High Dephospho-Uncarboxylated Matrix Gla Protein Concentrations, a Plasma Biomarker of Vitamin K, in Relation to Frailty: the Longitudinal Aging Study Amsterdam. Eur. J. Nutr. 59, 1243–1251. 10.1007/s00394-019-01984-9 [DOI] [PubMed] [Google Scholar]
  15. Misra D., Booth S. L., Tolstykh I., Felson D. T., Nevitt M. C., Lewis C. E., et al. (2013). Vitamin K Deficiency Is Associated with Incident Knee Osteoarthritis. Am. J. Med. 126, 243–248. 10.1016/j.amjmed.2012.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nakagawa K., Hirota Y., Sawada N., Yuge N., Watanabe M., Uchino Y., et al. (2010). Identification of UBIAD1 as a Novel Human Menaquinone-4 Biosynthetic Enzyme. Nature 468, 117–121. 10.1038/nature09464 [DOI] [PubMed] [Google Scholar]
  17. Nelsestuen G. L., Zytkovicz T. H., Howard J. B. (1974). The Mode of Action of Vitamin K. J. Biol. Chem. 249, 6347–6350. 10.1016/s0021-9258(19)42259-x [DOI] [PubMed] [Google Scholar]
  18. Neogi T., Booth S. L., Zhang Y. Q., Jacques P. F., Terkeltaub R., Aliabadi P., et al. (2006). Low Vitamin K Status Is Associated with Osteoarthritis in the Hand and Knee. Arthritis Rheum. 54, 1255–1261. 10.1002/art.21735 [DOI] [PubMed] [Google Scholar]
  19. Oka H., Akune T., Muraki S., En-yo Y., Yoshida M., Saika A., et al. (2009). Association of Low Dietary Vitamin K Intake with Radiographic Knee Osteoarthritis in the Japanese Elderly Population: Dietary Survey in a Population-Based Cohort of the ROAD Study. J. Orthopaedic Sci. 14, 687–692. 10.1007/s00776-009-1395-y [DOI] [PubMed] [Google Scholar]
  20. Pilleron S., Weber D., Weber D., Pérès K., Colpo M., Gomez-Cabrero D., et al. (2019). Patterns of Circulating Fat-Soluble Vitamins and Carotenoids and Risk of Frailty in Four European Cohorts of Older Adults. Eur. J. Nutr. 58, 379–389. 10.1007/s00394-017-1602-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Price P. A., Otsuka A. A., Poser J. W., Kristaponis J., Raman N. (1976). Characterization of a Gamma-Carboxyglutamic Acid-Containing Protein from Bone. Proc. Natl. Acad. Sci. U.S.A. 73, 1447–1451. 10.1073/pnas.73.5.1447 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Price P. A., Urist M. R., Otawara Y. (1983). Matrix Gla Protein, a New γ-carboxyglutamic Acid-Containing Protein Which Is Associated with the Organic Matrix of Bone. Biochem. Biophysical Res. Commun. 117, 765–771. 10.1016/0006-291x(83)91663-7 [DOI] [PubMed] [Google Scholar]
  23. Rivas D. A., Morris E. P., Haran P. H. (2012). Increased Ceramide Content and NFκB Signaling May Contribute to the Attenuation of Anabolic Signaling after Resistance Exercise in Aged Males. J. Appl. Physiol. 113, 1727–1736. 10.1152/japplphysiol.00412.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Satake S., Shimada H., Yamada M. (2017). Prevalence of Frailty Among Community-Dwellers and Outpatients in Japan as Defined by the Japanese Version of the Cardiovascular Health Study Criteria. Geriatr. Gerontol. Int. 17, 2629–2634. 10.1111/ggi.13129 [DOI] [PubMed] [Google Scholar]
  25. Shea M. K., Kritchevsky S. B., Loeser R. F., Booth S. L. (2020). Vitamin K Status and Mobility Limitation and Disability in Older Adults: The Health, Aging, and Body Composition Study. J. Gerontol. A. Biol. Sci. Med. Sci. 75, 792–797. 10.1093/gerona/glz108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shea M. K., Loeser R. F., Hsu F.-C., Booth S. L., Nevitt M., Simonsick E. M., et al. Health ABC Study (2016). Vitamin K Status and Lower Extremity Function in Older Adults: The Health Aging and Body Composition Study. Gerona 71, 1348–1355. 10.1093/gerona/glv209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Smith C., Lewis J. R., Sim M., Lim W. H., Lim E. M., Blekkenhorst L. C., et al. (2021). Higher Undercarboxylated to Total Osteocalcin Ratio Is Associated with Reduced Physical Function and Increased 15‐Year Falls‐Related Hospitalizations: The Perth Longitudinal Study of Aging Women. J. Bone Miner Res. 36, 523–530. 10.1002/jbmr.4208 [DOI] [PubMed] [Google Scholar]
  28. Stenflo J., Fernlund P., Egan W., Roepstorff P. (1974). Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin. Proc. Natl. Acad. Sci. U.S.A. 71, 2730–2733. 10.1073/pnas.71.7.2730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Su X., Zhou J., Wang W., Yin C., Wang F. (2022). VK2 Regulates Slow-Twitch Muscle Fibers Expression and Mitochondrial Function via SIRT1/SIRT3 Signaling. Nutrition 93, 111412. 10.1016/j.nut.2021.111412 [DOI] [PubMed] [Google Scholar]
  30. Sundaram K. S., Lev M. (1988). Warfarin Administration Reduces Synthesis of Sulfatides and Other Sphingolipids in Mouse Brain. J. Lipid Res. 29, 1475–1479. 10.1016/s0022-2275(20)38426-1 [DOI] [PubMed] [Google Scholar]
  31. Suttie J. W., Booth S. L. (2011). Vitamin K. Adv. Nutr. 2, 440–441. 10.3945/an.111.000786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tabb M. M., Sun A., Zhou C., Grün F., Errandi J., Romero K., et al. (2003). Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR. J. Biol. Chem. 278, 43919–43927. 10.1074/jbc.M303136200 [DOI] [PubMed] [Google Scholar]
  33. Tarvainen M., Fabritius M., Yang B. (2019). Determination of Vitamin K Composition of Fermented Food. Food Chem. 275, 515–522. 10.1016/j.foodchem.2018.09.136 [DOI] [PubMed] [Google Scholar]
  34. Tsugawa N., Shiraki M., Suhara Y., Kamao M., Tanaka K., Okano T. (2006). Vitamin K Status of Healthy Japanese Women: Age-Related Vitamin K Requirement for Gamma-Carboxylation of Osteocalcin. Am. J. Clin. Nutr. 83, 380–386. 10.1093/ajcn/83.2.380 [DOI] [PubMed] [Google Scholar]
  35. van Ballegooijen A. J., van Putten S. R., Visser M., Beulens J. W., Hoogendijk E. O. (2018). Vitamin K Status and Physical Decline in Older Adults-The Longitudinal Aging Study Amsterdam. Maturitas 113, 73–79. 10.1016/j.maturitas.2018.04.013 [DOI] [PubMed] [Google Scholar]
  36. Yaegashi Y., Onoda T., Tanno K., Kuribayashi T., Sakata K., Orimo H. (2008). Association of Hip Fracture Incidence and Intake of Calcium, Magnesium, Vitamin D, and Vitamin K. Eur. J. Epidemiol. 23, 219–225. 10.1007/s10654-008-9225-7 [DOI] [PubMed] [Google Scholar]
  37. Zanin M., Germinario E., Dalla Libera L. (2008). Trophic Action of Sphingosine 1-phosphate in Denervated Rat Soleus Muscle. Am. J. Physiol. Cel Physiol 294, C36–C46. 10.1152/ajpcell.00164.2007 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Aging are provided here courtesy of Frontiers Media SA

RESOURCES